Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

• Status: Terminated
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the pharmacokinetics of clarithromycin which is used for premature infants with ureaplasma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Clarithromycin

Criteria

Inclusion Criteria:

• birthweight < 1500gm or GA < 32 weeks

• transtracheal aspirate/gastric juice ; ureaplasma/mycoplasma(+)

Exclusion Criteria:

• sepsis, hypotension, shock

• major congenital anomaly